Circa Scientific has launched its CrossWise RF transseptal access system, designed for precise puncturing of the heart's septal wall using radiofrequency energy. Inquis Medical completed enrollment in a pivotal trial for its Aventus thrombectomy system, aimed at evaluating the safety and efficacy of the device for treating thrombus. Medtronic entered into an exclusive U.S. distribution agreement with Contego Medical, becoming the sole distributor for Contego's portfolio of products. Relief Cardiovascular secured $12 million in Series A funding to initiate a first-in-human feasibility study for its Relief System, a smart transcatheter implant. Johnson & Johnson MedTech received CE mark approval for its dual-energy ThermoCool SmartTouch SF catheter, featuring irrigated, contact-force sensing capabilities. However, Johnson & Johnson MedTech has temporarily paused all U.S. cases using its Varipulse pulsed field ablation (PFA) system due to stroke reports. AerWave completed a first-in-human feasibility study of its disease-modifying ultrasound lung denervation therapy, aimed at treating chronic obstructive pulmonary disease, and raised $12 million to advance this therapy.